What researchers published on Tripla negatív emlőrák
3466 papers, newest first.
Showing 20 of 3466
ÁttekintésThe HLA-E-NKG2A axis in breast cancer: an emerging NK-cell checkpoint and therapeutic target.Frontiers in immunology
Patient-reported outcomes from ASCENT-03: sacituzumab govitecan vs chemotherapy in advanced triple-negative breast cancer.The oncologist
Correction: Eustace et al. TP53 Mutation-Specific Dysregulation of Store-Operated Calcium Entry and Apoptotic Sensitivity in Triple-Negative Breast Cancer. Cancers 2025, 17, 1614.Cancers
Effectiveness and Toxicity Burden of Pembrolizumab in Combination With Neoadjuvant Chemotherapy for Stage II/III Triple Negative Breast Cancer: A Real-World Analysis From Alberta, Canada.American journal of clinical oncology
Relevance of toll-like receptor-4 in the pathogenesis of triple negative breast cancer.Molecular biology reports
CDK4/6-Mediated Growth Arrest Enhances Cell Stiffness and Contractility in RB-Proficient Triple-Negative Breast Cancer Cells in 3D Hydrogels.Tissue engineering. Part A
Treatment-associated remodeling of a mitochondrial translation-related gene set in paired pretreatment and residual triple-negative breast tumors.Neoplasia (New York, N.Y.)
Comprehensive characterization of the cellular and molecular consequences of LCN2 loss in MDA-MB-231 triple-negative breast cancer cells.Frontiers in cell and developmental biology
Claims-defined adrenal insufficiency, hypothyroidism, and type 1 diabetes after immune checkpoint inhibitor initiation in patients with triple-negative breast cancer in Japan.Breast cancer (Tokyo, Japan)
ÁttekintésGlutamine as a context-dependent regulator controlling metabolism and immunity in triple-negative breast cancer.Cell communication and signaling : CCS
MetaanalízisReal-world effectiveness and safety of neoadjuvant pembrolizumab in early-stage triple-negative breast cancer: a systematic review and meta-analysis.BMC cancer
Analyzing per- and polyfluoroalkyl substances (PFAS) in triple-negative breast cancer (TNBC): an integrative transcriptomic and computational study.Cell biology and toxicology
Antibody-drug conjugates therapy for triple-negative breast cancer: a systematic review and meta-analysis.Frontiers in medicine
CD39-associated myeloid-T-cell coordination within an immunoregulatory neighborhood linked to treatment resistance in triple-negative breast cancer.Breast cancer research : BCR
Bifunctional EGFR/CD44-Targeted Diabody-Decorated Doxorubicin-Loaded Solid Lipid Nanoparticles for Targeted Therapy in Triple-Negative Breast Cancer.Advanced pharmaceutical bulletin
Egonol restores tamoxifen sensitivity via the miR-3529-5p-CLOCK axis in triple-negative breast cancer cells.Fitoterapia
Effect of Exosome-loaded hsa-miR-203a-3p on Triple Negative Breast Cancer Cell Viability, Migration, and Gene Targets: In Silico and In Vitro Study.Advanced pharmaceutical bulletin
CD97 Modulates M1-Like Macrophage Activation and Function to Influence the Immune Microenvironment and Tumor Progression in Triple-Negative Breast Cancer.Journal of inflammation research
CircEML1 upregulates BTG2 to suppress the progression of triple-negative breast cancer.Biology direct
Biotin-Functionalized Multi-Stimuli-Responsive Polymeric Prodrug for Receptor-Mediated and Mitochondria-Targeted Codelivery of Camptothecin and Protocatechualdehyde.Biomacromolecules